APFED Announces 2024 AAAAI Abstract Award Recipients

Two recipients are recognized for best-scoring abstracts focused on eosinophilic gastrointestinal diseases (EGIDs)

ATLANTA, GA — The American Partnership for Eosinophilic Disorders (APFED) announced the recipients of the 2024 AAAAI/APFED Best Abstract on EGIDs Awards for research presented during the Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) held in Washington, D.C. February 23-26, 2024.

The 2024 AAAAI/APFED Best Abstract on EGIDs recipients are Edsel M. Abud, MD, PhD, Scripps Clinic, for his abstract entitled, “Dysregulated Adenosine Pathway Decreases Fibroblast Homeostatic Function in Eosinophilic Esophagitis” and Nicole L. Wolfset, MD, Children’s Hospital of Philadelphia, for her abstract entitled, “Dupilumab Reduces T-cell Antigen-Specific Response in Eosinophilic Esophagitis.”

Dr. Abud’s abstract presented data that suggests EoE fibroblasts have reduced CD73 expression and enzymatic activity as well as increased basal migration compared to normal fibroblasts, suggesting that changes in EoE fibroblast homeostatic functions are in part due to dysregulated CD73 activity.

Dr. Wolfset’s abstract presented data suggesting that dupilumab may reduce memory T cell proliferation to specific food antigens over time.

The AAAAI/APFED Best Abstract on EGIDs Awards honor outstanding research abstracts on eosinophil-associated gastrointestinal diseases (EGIDs).  APFED funds the $750 awards to help enable researchers travel to present their findings more broadly to their peers. Abstract award winners may go on to successfully compete for grants from APFED or from other funding mechanisms.

The awards were made possible thanks to the generous donations to APFED’s HOPE on the Horizon Research Program. For more information or to make a donation, visit apfed.org.

About the American Partnership for Eosinophilic Disorders (APFED)

The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy. apfed.org